We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+15.8%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$399M
AUM Growth
+$67.3M
Cap. Flow
+$22.3M
Cap. Flow %
5.59%
Top 10 Hldgs %
51.07%
Holding
93
New
14
Increased
46
Reduced
19
Closed
12

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$7.78M
2
CRM icon
Salesforce
CRM
+$4.98M
3
CHD icon
Church & Dwight Co
CHD
+$4.62M
4
JNJ icon
Johnson & Johnson
JNJ
+$4.56M
5
EXAS
Exact Sciences
EXAS
+$3.17M

Sector Composition

Rank Sector Weight
1 Healthcare 37.73%
2 Technology 16.75%
3 Financials 12.31%
4 Consumer Discretionary 8.53%
5 Communication Services 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
1
Intuitive Surgical
ISRG
$121B
$38.7M 9.72%
203,661
-1,965
-1% -$349K
MA icon
2
Mastercard
MA
$477B
$35.2M 8.84%
149,675
-6,053
-4% -$1.3M
AAPL icon
3
Apple
AAPL
$4.89T
$24.1M 6.05%
508,212
-5,604
-1% -$238K
ABMD
4
DELISTED
Abiomed Inc
ABMD
$18.3M 4.58%
63,915
-1,734
-3% -$576K
ILMN icon
5
Illumina
ILMN
$29.4B
$17.1M 4.3%
56,723
+3,634
+7% +$1.06M
EXAS
6
DELISTED
Exact Sciences
EXAS
$17M 4.27%
196,620
+37,295
+23% +$3.17M
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.91T
$15.5M 3.88%
263,000
+18,980
+8% +$1.07M
XYZ
8
Block Inc
XYZ
$45.9B
$14M 3.5%
186,390
+43,685
+31% +$3.17M
IDXX icon
9
Idexx Laboratories
IDXX
$42.9B
$13.4M 3.37%
60,041
-4,445
-7% -$918K
REGN icon
10
Regeneron Pharmaceuticals
REGN
$68.8B
$10.2M 2.55%
24,732
+6,980
+39% +$2.87M
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$121B
$10.1M 2.54%
54,950
+8,930
+19% +$1.65M
JPM icon
12
JPMorgan Chase
JPM
$939B
$9.18M 2.3%
90,688
-702
-0.8% -$72.3K
VFC icon
13
VF Corp
VFC
$6.68B
$8.62M 2.16%
105,361
-106
-0.1% -$8.27K
ADBE icon
14
Adobe
ADBE
$89.5B
$8.22M 2.06%
+30,848
New +$7.78M
PG icon
15
Procter & Gamble
PG
$343B
$6.76M 1.7%
64,943
-482
-0.7% -$46.9K
LOW icon
16
Lowe's Companies
LOW
$116B
$6.46M 1.62%
58,980
-391
-0.7% -$39K
MSFT icon
17
Microsoft
MSFT
$2.84T
$6.3M 1.58%
53,248
+178
+0.3% +$19.4K
INTC icon
18
Intel
INTC
$466B
$5.83M 1.46%
108,034
+707
+0.7% +$35.9K
CVX icon
19
Chevron
CVX
$388B
$5.74M 1.44%
46,164
+196
+0.4% +$23.2K
MCD icon
20
McDonald's
MCD
$188B
$5.67M 1.42%
29,651
-112
-0.4% -$20.3K
LMT icon
21
Lockheed Martin
LMT
$134B
$5.6M 1.41%
18,524
+33
+0.2% +$9.68K
VZ icon
22
Verizon
VZ
$194B
$5.38M 1.35%
91,016
+188
+0.2% +$10.6K
ALGN icon
23
Align Technology
ALGN
$12B
$5.38M 1.35%
18,905
+1,010
+6% +$241K
MMM icon
24
3M
MMM
$89B
$5.28M 1.32%
30,174
+231
+0.8% +$38.9K
JNJ icon
25
Johnson & Johnson
JNJ
$635B
$5.25M 1.32%
37,511
+34,050
+984% +$4.56M

Similar funds

Biondo Investment Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Biondo Investment Advisors held 93 positions worth $399M, up 20% from $331M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Biondo Investment Advisors deployed $22.3M of net new capital in Q1 2019, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Adobe: 30,848 shares worth $8.22M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Mastercard, an estimated $1.3M trimmed.

  • Biondo Investment Advisors's largest Q1 2019 buy was Adobe: 30,848 shares worth $8.22M.
  • Biondo Investment Advisors added most to Johnson & Johnson in Q1 2019, an estimated $4.56M increase.
  • Biondo Investment Advisors's biggest Q1 2019 reduction was Mastercard, cutting an estimated $1.3M.
  • Biondo Investment Advisors fully exited iShares MSCI EAFE ETF in Q1 2019, selling an estimated $9.86M.
  • Biondo Investment Advisors's ten largest holdings make up 51% of its $399M portfolio in Q1 2019.
  • Biondo Investment Advisors opened 14 new positions and closed 12 in Q1 2019.
  • Biondo Investment Advisors's portfolio value rose 20% quarter-over-quarter to $399M.

Based on Biondo Investment Advisors's 13F filing for Q1 2019, filed 8 May 2019.